TCAN — Transcanna Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Transcanna Holdings, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2017 November 30th | 2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.24 | 6.96 | 4 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.069 | 0.099 | -1.01 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.191 | 2.08 | 25.8 | 21.3 | 15.3 |
| Operating Profit | -0.191 | -2.08 | -25.6 | -14.3 | -11.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.191 | -2.16 | -25.8 | -17.4 | -13.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.191 | -2.16 | -25.8 | -17.1 | -13.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.191 | -2.16 | -25.8 | -17.1 | -13.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.191 | -2.16 | -25.8 | -17.1 | -13.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.018 | -0.204 | -0.454 | -0.334 | -0.221 |
| Dividends per Share |